BeelenR.H.J., HendrickxRJBM, EestermansI.L., DoppE.A., WijffelsJFAMMilky spots can be considered as omentum associated lymphoid tissue (OALT). In: ImhofB., ed. Lymphatic Tissues and in Vivo Immune Responses.New York: Dekker; 1991: 519–24.
4.
KotenJ.W., den OtterW.Are omental milky spots an intestinal thymus?Lancet1991; 338: 1189–90.
BeelenR.H.J.Role of omental milky spots in the local immune response.Lancet1992; 339: 689.
7.
ShimotsumaM., HagiwaraA.Omental milky spots and the local immune response.Lancet1992; 339: 1232.
8.
KristL.F.G., KoenenJ.P.M., MeijerS., BeelenR.H.J.Ontogenic development of human milky spots.Anat Rec1997; 249: 399–404.
9.
WijffelsJFAM, HendrickxRJBM, SteenbergenJ.J.E., EestermansI.L., BeelenR.H.J.Milky spots in the mouse omentum may play an important role in the origin of peritoneal macrophages.Res Immunol1992; 143: 401–9.
10.
van VugtE., KamperdijkE.W.A., BeelenR.H.J.A congeneic rat model to study migration in vivo.Transplant Proc1993; 25: 2808–10.
11.
Liebermann-MeffertD., WhiteH.The Greater Omentum: Anatomy, Physiology, Pathology and Surgery, with a Historical Survey.Berlin: Springer; 1983.
12.
van VugtE., van RijthovenE.A.M., KamperdijkE.W.A., BeelenR.H.J.Omental milky spots in the local immune response in the peritoneal cavity of rats.Anat Rec1996; 244: 235–45.
13.
ShimotsumaM., KawataM., HagiwaraA., TakahashiT.Milky spots in the human greater omentum.Acta Anat1989; 136: 211–16.
14.
KristL.F.G., BrouwerJ.J.E., EstermansI.L., CuestaM.A., MeijerS., BeelenR.H.J.Cellular composition of human milky spots.Anat Rec1995; 241: 163–74.
15.
BeelenR.H.J., HekkingL.H.P., ZareieM., van den BornJ.Rat models in peritoneal dialysis.Nephrol Dial Transplant2001; 16: 672–4.
16.
HekkingL.H.P., ZareieM., DriesprongB.A.J., FaictD., WeltenA.G.A., de GreeuwI.Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.J Am Soc Nephrol2001; 12: 2775–86.
17.
ZareieM., HekkingL.H.P., WeltenA.G.A., DriesprongB.A.J., Schadee-EestermansI., FaictD.Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.Nephrol Dial Transplant2003; 18: 2629–37.
18.
ZareieM., van LambalgenA.A., ter WeeP.M., HekkingL.H.P., KeuningE.D., Schadee-EestermansI.L.Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.Perit Dial Int2005; 25: 58–67.
19.
ZareieM., KeuningE.D., ter WeeP.M., BeelenR.H.J., van den BornJ.PD-fluid induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.Nephrol Dial Transplant2004; [in press].
LiJ., YangZ., SuH., ZhangK.Effect of macrophage nitric oxide on the ultrafiltration failure during long-term peritoneal dialysis.Zhongguo Yi Xue Ke Xue Yuan Xue Bao2000; 22: 280–3.
22.
GarosiG., Di PaoloN.Recent advances in peritoneal morphology: The milky spots in peritoneal dialysis.Adv Perit Dial2001; 17: 25–8.
23.
HagiwaraA., TakanhashiT., SawaiK., TaniguchiH., ShimutsomaM., OkanaS.Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice.Cancer Res1993; 53: 687–92.
24.
KristL.F.G., KerremansM., CalameW., Broekhuis-FluitsmaD.M., EestermansI.L., MeijerS.Milky spots in the omentum are the predominant sites of local tumor cell proliferation and accumulation in the peritoneal cavity.Cancer Immunol Immunother1998; 47: 205–12.
25.
Lopez CardozoA.M., GuptaM., KoppeM.J., MeijerS., van LeeuwenP.A., BeelenR.H.J.Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: An experimental model of peritoneal metastasis in rats.Eur J Surg Oncol2001; 27: 359–63.
26.
KristL.F.G., KerremansM., KoenenH., BlijlevenH., EestermansI.L., CalameW.Novel isolation and purification method permitting functional cytotoxic studies of macrophages from milky spots in the greater omentum.J Immunol Methods1995; 184: 253–61.
27.
KoenenJHPM, SmitM.J., SimmelinkMMJA, SchuurmanB., BeelenR.H.J., MeijerS.Effect of intraperitoneal administration of granulocyte/macrophage-colony-stimulating factor in rats on omental milky-spot composition and tumoricidal activity in vivo and in vitro.Cancer Immunol Immunother1996; 42: 310–16.
28.
BenedetJ.L., BenderH., JonesH., NganH.Y., PecorelliS.FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.Int J Gynaecol Obstet2000; 70: 209–62.
29.
MochuzukiY., NakanishiH., KoderaY., ItoS., YamamuraY., KatoT.TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line.Clin Exp Metastasis2004; 21: 39–47.